Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, has updated ...

Men’s Health Month 2025 encourages men to adopt preventive care and healthy lifestyle habits to improve overall health ...

With early detection of prostate cancer recognised as a critical part in reducing the disease’s mortality rate, PanGIA ...

Johnson & Johnson has reported data from a Phase I trial of pasritamig for metastatic castration-resistant prostate cancer ...

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

Darolutamide (Nubeqa) is granted FDA approval for metastatic castration-sensitive prostate cancer, enhancing survival and ...

Scientists say they have worked out a machine learning method with the ability to provide close to precise survival estimates of patients afflicted ...

Seven-year follow-up data on over 1400 patients show radium-223's long-term safety, with a low 2% secondary malignancy rate, reflecting real-world use.

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date ... but similar survival outcomes when both groups had equal access to care.

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, ...